🇦🇺 Australia Country × Condition
advanced solid tumors Clinical Trials in Australia
Active clinical trials for advanced solid tumors with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT06384352 Phase 1
Recruiting
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
Enrollment
500 pts
Country
🇦🇺 Australia
MediLink Therapeutics (Suzhou) Co.,...
View Trial → NCT07222969 Phase 1, Phase 2
Recruiting
A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors
Enrollment
146 pts
Country
🇦🇺 Australia
Vibrant Sciences Limited
View Trial → NCT07266428 Phase 1, Phase 2
Recruiting
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
Enrollment
170 pts
Country
🇦🇺 Australia
Ottimo Pharma Limited
View Trial → NCT07042100 Phase 1
Recruiting
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Enrollment
177 pts
Country
🇦🇺 Australia
Sun Pharma Advanced Research Compan...
View Trial → Frequently Asked Questions
How many advanced solid tumors clinical trials are active in Australia?
There are currently 4 active clinical trials for advanced solid tumors with sites in Australia, of which 4 are actively recruiting patients.
How can I join a advanced solid tumors clinical trial in Australia?
To join a advanced solid tumors clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are advanced solid tumors trials in Australia?
Active advanced solid tumors trials in Australia span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology